AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
AAPL   317.94 (-0.10%)
MSFT   183.25 (+1.02%)
FB   225.09 (-0.16%)
GOOGL   1,433.52 (+1.08%)
AMZN   2,442.37 (+1.72%)
NVDA   355.02 (+4.58%)
CGC   17.37 (-20.03%)
BABA   207.39 (+3.96%)
MU   47.91 (+3.10%)
GE   6.57 (-3.10%)
TSLA   835.00 (+3.62%)
AMD   53.80 (+3.98%)
T   30.86 (-0.64%)
ACB   14.08 (-8.21%)
F   5.71 (-2.39%)
GILD   77.83 (+3.33%)
DIS   117.30 (+0.47%)
NFLX   419.73 (+1.52%)
BAC   24.12 (-2.98%)
BA   145.85 (-2.65%)
Log in

NASDAQ:CTSOCytosorbents News Headlines

$10.21
+0.55 (+5.69 %)
(As of 05/29/2020 04:00 PM ET)
Add
Compare
Today's Range
$9.62
Now: $10.21
$10.24
50-Day Range
$6.59
MA: $9.21
$10.59
52-Week Range
$3.49
Now: $10.21
$11.24
Volume385,515 shs
Average Volume762,409 shs
Market Capitalization$369.92 million
P/E RatioN/A
Dividend YieldN/A
Beta0.52

Headlines

Cytosorbents (NASDAQ CTSO) News Headlines

Source:
DateHeadline
CytoSorbents Announces Virtual Annual Meeting - PRNewswireCytoSorbents Announces Virtual Annual Meeting - PRNewswire
www.prnewswire.com - May 27 at 7:16 PM
CytoSorbents Announces Virtual Annual MeetingCytoSorbents Announces Virtual Annual Meeting
finance.yahoo.com - May 27 at 2:14 PM
CTSO: Q1 2020: CTSO Nabs FDA breakthrough designation and European approval for ticagrelor removal, Q1 Product revenue sets new record, Moving PT to $15/shareCTSO: Q1 2020: CTSO Nabs FDA breakthrough designation and European approval for ticagrelor removal, Q1 Product revenue sets new record, Moving PT to $15/share
finance.yahoo.com - May 19 at 1:28 PM
Cytosorbents Corp (NASDAQ:CTSO) Receives Consensus Recommendation of "Buy" from BrokeragesCytosorbents Corp (NASDAQ:CTSO) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - May 19 at 6:48 AM
BRIEF-Cytosorb Approved & Available In European Union- Cytosorbents - ReutersBRIEF-Cytosorb Approved & Available In European Union- Cytosorbents - Reuters
www.reuters.com - May 13 at 3:51 AM
CytoSorb® is EU Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic Surgery - PRNewswireCytoSorb® is EU Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic Surgery - PRNewswire
www.prnewswire.com - May 12 at 5:50 PM
CytoSorb OKd in Europe to remove rivaroxaban during cardiothoracic surgeryCytoSorb OK'd in Europe to remove rivaroxaban during cardiothoracic surgery
seekingalpha.com - May 12 at 7:32 AM
CytoSorb® is E.U. Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic SurgeryCytoSorb® is E.U. Approved to Remove Rivaroxaban, a Leading Factor Xa Inhibitor and Novel Oral Anticoagulant, During On-Pump Cardiothoracic Surgery
finance.yahoo.com - May 12 at 7:32 AM
$9.08 Million in Sales Expected for Cytosorbents Corp (NASDAQ:CTSO) This Quarter$9.08 Million in Sales Expected for Cytosorbents Corp (NASDAQ:CTSO) This Quarter
www.americanbankingnews.com - May 12 at 1:36 AM
 Analysts Anticipate Cytosorbents Corp (NASDAQ:CTSO) Will Announce Earnings of -$0.09 Per Share Analysts Anticipate Cytosorbents Corp (NASDAQ:CTSO) Will Announce Earnings of -$0.09 Per Share
www.americanbankingnews.com - May 11 at 12:12 AM
The Charts of Cytosorbents Suggest We Might See Further Gains AheadThe Charts of Cytosorbents Suggest We Might See Further Gains Ahead
finance.yahoo.com - May 8 at 5:00 PM
B. Riley Weighs in on Cytosorbents Corps Q2 2020 Earnings (NASDAQ:CTSO)B. Riley Weighs in on Cytosorbents Corp's Q2 2020 Earnings (NASDAQ:CTSO)
www.americanbankingnews.com - May 8 at 1:00 PM
Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at Maxim GroupCytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at Maxim Group
www.americanbankingnews.com - May 8 at 6:22 AM
B. Riley Analysts Boost Earnings Estimates for Cytosorbents Corp (NASDAQ:CTSO)B. Riley Analysts Boost Earnings Estimates for Cytosorbents Corp (NASDAQ:CTSO)
www.americanbankingnews.com - May 7 at 6:31 PM
Cytosorbents Corp (CTSO) Q1 2020 Earnings Call Transcript - Motley FoolCytosorbents Corp (CTSO) Q1 2020 Earnings Call Transcript - Motley Fool
www.fool.com - May 7 at 4:28 AM
Cytosorbents Corp (CTSO) Q1 2020 Earnings Call TranscriptCytosorbents Corp (CTSO) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 7 at 4:28 AM
Cytosorbents (NASDAQ:CTSO) Price Target Increased to $16.00 by Analysts at B. RileyCytosorbents (NASDAQ:CTSO) Price Target Increased to $16.00 by Analysts at B. Riley
www.americanbankingnews.com - May 7 at 12:30 AM
Cytosorbents (NASDAQ:CTSO) PT Raised to $14.00Cytosorbents (NASDAQ:CTSO) PT Raised to $14.00
www.americanbankingnews.com - May 6 at 11:58 PM
Cytosorbents (NASDAQ:CTSO) Announces  Earnings Results, Beats Expectations By $0.04 EPSCytosorbents (NASDAQ:CTSO) Announces Earnings Results, Beats Expectations By $0.04 EPS
www.americanbankingnews.com - May 6 at 8:48 PM
Edited Transcript of CTSO.OQ earnings conference call or presentation 5-May-20 8:45pm GMT - Yahoo FinanceEdited Transcript of CTSO.OQ earnings conference call or presentation 5-May-20 8:45pm GMT - Yahoo Finance
finance.yahoo.com - May 6 at 1:02 PM
Cytosorbents Corporation (CTSO) CEO Phillip Chan on Q1 2020 Results - Earnings Call Transcript - Seeking AlphaCytosorbents Corporation (CTSO) CEO Phillip Chan on Q1 2020 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 6 at 5:01 AM
BRIEF-Cytosorbents Reports Qtrly Loss Per Share Of $0.10 - ReutersBRIEF-Cytosorbents Reports Qtrly Loss Per Share Of $0.10 - Reuters
www.reuters.com - May 5 at 11:10 PM
CytoSorbents Reports First Quarter 2020 Financial and Operational Results - PRNewswireCytoSorbents Reports First Quarter 2020 Financial and Operational Results - PRNewswire
www.prnewswire.com - May 5 at 4:21 PM
CytoSorbents Reports First Quarter 2020 Financial and Operational ResultsCytoSorbents Reports First Quarter 2020 Financial and Operational Results
finance.yahoo.com - May 5 at 4:21 PM
BRIEF-Cytosorbents Promotes Vincent J. Capponi To President - ReutersBRIEF-Cytosorbents Promotes Vincent J. Capponi To President - Reuters
www.reuters.com - May 4 at 9:48 AM
CytoSorbents Promotes Vincent J. Capponi to PresidentCytoSorbents Promotes Vincent J. Capponi to President
finance.yahoo.com - May 4 at 9:48 AM
CytoSorbents secures $1.1M in new funding via NJ program - Seeking AlphaCytoSorbents secures $1.1M in new funding via NJ program - Seeking Alpha
seekingalpha.com - April 29 at 8:01 AM
Cytosorbents: COVID-19 Has Presented A Bullish Opportunity - Seeking AlphaCytosorbents: COVID-19 Has Presented A Bullish Opportunity - Seeking Alpha
seekingalpha.com - April 29 at 8:01 AM
CytoSorbents to Report Q1 2020 Operating and Financial Results - PRNewswireCytoSorbents to Report Q1 2020 Operating and Financial Results - PRNewswire
www.prnewswire.com - April 28 at 4:55 PM
CytoSorbents to Report Q1 2020 Operating and Financial ResultsCytoSorbents to Report Q1 2020 Operating and Financial Results
finance.yahoo.com - April 28 at 11:55 AM
New medical chief at CytoSorbents - Seeking AlphaNew medical chief at CytoSorbents - Seeking Alpha
seekingalpha.com - April 27 at 10:14 AM
Cytosorbents Appoints Dr. Efthymios N. Deliargyris, M.D., As Chief Medical OfficerCytosorbents Appoints Dr. Efthymios N. Deliargyris, M.D., As Chief Medical Officer
finance.yahoo.com - April 27 at 10:14 AM
Form 8-K Cytosorbents Corp For: Apr 20 - StreetInsider.comForm 8-K Cytosorbents Corp For: Apr 20 - StreetInsider.com
www.streetinsider.com - April 20 at 11:53 PM
BRIEF-Cytosorbents Entered Into Into Amendment To Open Market Sale Agreement With Jefferies Relating To Sale Of Shares Of Common Stock - ReutersBRIEF-Cytosorbents Entered Into Into Amendment To Open Market Sale Agreement With Jefferies Relating To Sale Of Shares Of Common Stock - Reuters
www.reuters.com - April 20 at 6:52 PM
Cytosorbents (CTSO) Announces FDA Grants Breakthrough Designation to CytoSorb for Removal of Ticagrelor During Cardiopulmonary Bypass in Emergent and Urgent Cardiothoracic Surgery - StreetInsider.comCytosorbents (CTSO) Announces FDA Grants Breakthrough Designation to CytoSorb for Removal of Ticagrelor During Cardiopulmonary Bypass in Emergent and Urgent Cardiothoracic Surgery - StreetInsider.com
www.streetinsider.com - April 20 at 8:50 AM
CytoSorbents up 7% premarket on Breakthrough Designation tag for CytoSorb - Seeking AlphaCytoSorbents up 7% premarket on Breakthrough Designation tag for CytoSorb - Seeking Alpha
seekingalpha.com - April 20 at 8:50 AM
Development Update: U.S. FDA Grants Breakthrough Designation to CytoSorb for Removal of Ticagrelor During Cardiopulmonary Bypass in Emergent and Urgent Cardiothoracic SurgeryDevelopment Update: U.S. FDA Grants Breakthrough Designation to CytoSorb for Removal of Ticagrelor During Cardiopulmonary Bypass in Emergent and Urgent Cardiothoracic Surgery
finance.yahoo.com - April 20 at 8:50 AM
Coronavirus Treatment Could Be in Hospitals Next Week, Cytosorbents CEO Says - TheStreetCoronavirus Treatment Could Be in Hospitals 'Next Week,' Cytosorbents CEO Says - TheStreet
www.thestreet.com - April 16 at 5:46 PM
Cramers lightning round: Amarin has been too much of a dice roll - CNBCCramer's lightning round: Amarin has been 'too much of a dice roll' - CNBC
www.cnbc.com - April 15 at 8:12 PM
BRIEF-Cytosorbents-New Study Suggests Cytosorb Improves Clinical Outcomes In Pneumonia Patients With Septic Shock, Acute Respiratory Distress Syndrome On Ecmo - ReutersBRIEF-Cytosorbents-New Study Suggests Cytosorb Improves Clinical Outcomes In Pneumonia Patients With Septic Shock, Acute Respiratory Distress Syndrome On Ecmo - Reuters
www.reuters.com - April 15 at 9:19 AM
New Study Suggests CytoSorb Improves Clinical Outcomes in Pneumonia Patients With Septic Shock and Acute Respiratory Distress Syndrome (ARDS) on ECMONew Study Suggests CytoSorb Improves Clinical Outcomes in Pneumonia Patients With Septic Shock and Acute Respiratory Distress Syndrome (ARDS) on ECMO
finance.yahoo.com - April 15 at 9:19 AM
Stock Alert: CytoSorbents Up 30% On FDAs Approval To Use CytoSorb For COVID-19 - NasdaqStock Alert: CytoSorbents Up 30% On FDA's Approval To Use CytoSorb For COVID-19 - Nasdaq
www.nasdaq.com - April 13 at 3:15 PM
Blood purification device can stabilize coronavirus patients: CytoSorbents CEO - Yahoo FinanceBlood purification device can stabilize coronavirus patients: CytoSorbents CEO - Yahoo Finance
finance.yahoo.com - April 13 at 3:15 PM
CytoSorbents stock jumps on FDA authorization for its device in COVID-19 patients - MarketWatchCytoSorbents' stock jumps on FDA authorization for its device in COVID-19 patients - MarketWatch
www.marketwatch.com - April 13 at 3:15 PM
CytoSorbents: FDA Grants EUA Of CytoSorb In Patients With COVID-19 Infection - NasdaqCytoSorbents: FDA Grants EUA Of CytoSorb In Patients With COVID-19 Infection - Nasdaq
www.nasdaq.com - April 13 at 9:11 AM
U.S. FDA Grants CytoSorb® Emergency Use Authorization for Use in Patients with COVID-19 InfectionU.S. FDA Grants CytoSorb® Emergency Use Authorization for Use in Patients with COVID-19 Infection
finance.yahoo.com - April 13 at 9:11 AM
CytoSorbents EBP device wins emergency OK to treat COVID-19 patients - Seeking AlphaCytoSorbents' EBP device wins emergency OK to treat COVID-19 patients - Seeking Alpha
seekingalpha.com - April 11 at 1:51 PM
CytoSorbents CEO to Discuss COVID-19 Pandemic and its CytoSorb® Treatment of Cytokine Storm in Cowen COVID-19 Series Conference Call Today - Yahoo FinanceCytoSorbents CEO to Discuss COVID-19 Pandemic and its CytoSorb® Treatment of Cytokine Storm in Cowen COVID-19 Series Conference Call Today - Yahoo Finance
finance.yahoo.com - April 4 at 5:10 PM
CytoSorbents CEO to Discuss COVID-19 Pandemic and its CytoSorb® Treatment of Cytokine Storm in Cowen COVID-19 Series Conference Call Today - PRNewswireCytoSorbents CEO to Discuss COVID-19 Pandemic and its CytoSorb® Treatment of Cytokine Storm in Cowen COVID-19 Series Conference Call Today - PRNewswire
www.prnewswire.com - April 3 at 5:24 PM
CytoSorbents CEO to Discuss COVID-19 Pandemic and its CytoSorb® Treatment of Cytokine Storm in Cowen COVID-19 Series Conference Call TodayCytoSorbents CEO to Discuss COVID-19 Pandemic and its CytoSorb® Treatment of Cytokine Storm in Cowen COVID-19 Series Conference Call Today
finance.yahoo.com - April 3 at 5:24 PM
This page was last updated on 5/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.